Josef Veselka

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications

Efficacy of Aficamten in Hypertrophic Cardiomyopathy Patients With Very-High Left Ventricular Outflow Tract Gradients.

Efficacy of Aficamten in Hypertrophic Cardiomyopathy Patients With Very-High Left Ventricular Outflow Tract Gradients.

Journal: The American journal of cardiology
Published: February 26, 2026

Refining Carotid Stenting Through Mesh-Integrated Stent Design.

Refining Carotid Stenting Through Mesh-Integrated Stent Design.

Journal: JACC. Cardiovascular interventions
Published: September 24, 2025

Practical Guide to the Management of Residual Obstruction After Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy.

Practical Guide to the Management of Residual Obstruction After Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy.

Journal: The Canadian journal of cardiology
Published: August 08, 2025

Impact of centre experience on complete clinical and haemodynamic response after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Impact of centre experience on complete clinical and haemodynamic response after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Journal: International journal of cardiology
Published: July 30, 2025

Editorial Commentary to The Role of Myocardial Radiofrequency Ablation in the Management of Obstructive Hypertrophic Cardiomyopathy.

Editorial Commentary to The Role of Myocardial Radiofrequency Ablation in the Management of Obstructive Hypertrophic Cardiomyopathy.

Journal: The Canadian journal of cardiology
Published: May 12, 2025

Reply to "alcohol septal ablation for obstructive hypertrophic cardiomyopathy: Outdated technique or promising future?"

Reply to "alcohol septal ablation for obstructive hypertrophic cardiomyopathy: Outdated technique or promising future?"

Journal: International journal of cardiology
Published: May 01, 2025

Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial.

Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial.

Journal: European heart journal
Published: April 16, 2025

Editorial Commentary to Personalized Treatment of Severe Obstructive Hypertrophic Cardiomyopathy: Combining Septal Reduction Therapy and Myosin Inhibitors.

Editorial Commentary to Personalized Treatment of Severe Obstructive Hypertrophic Cardiomyopathy: Combining Septal Reduction Therapy and Myosin Inhibitors.

Journal: The Canadian journal of cardiology
Published: February 25, 2025

Complete Clinical and Hemodynamic Response to Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy.

Complete Clinical and Hemodynamic Response to Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy.

Journal: JACC. Cardiovascular interventions
Published: February 15, 2025

Comparable outcomes in single versus multiple septal branches alcohol ablation for obstructive hypertrophic cardiomyopathy.

Comparable outcomes in single versus multiple septal branches alcohol ablation for obstructive hypertrophic cardiomyopathy.

Journal: International journal of cardiology
Published: December 12, 2024

Aficamten and Cardiopulmonary Exercise Test Performance: A Substudy of the SEQUOIA-HCM Randomized Clinical Trial.

Aficamten and Cardiopulmonary Exercise Test Performance: A Substudy of the SEQUOIA-HCM Randomized Clinical Trial.

Journal: JAMA cardiology
Published: September 04, 2024

It has been 30 years since the first alcohol septal ablation for hypertrophic obstructive cardiomyopathy was performed.

It has been 30 years since the first alcohol septal ablation for hypertrophic obstructive cardiomyopathy was performed.

Journal: Swiss medical weekly
Published: August 18, 2024
Showing 1-12 of 175

Last Updated: 09/26/2026